Global and China Biodegradable Plastics Industry Report, 2013-2016
  • Mar./2014
  • Hard Copy
  • USD $2,400
  • Pages:102
  • Single User License
    (PDF Unprintable)       
  • USD $2,250
  • Code: ALZ-001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,400
  • Hard Copy + Single User License
  • USD $2,600
      

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties developed so far, only plastarch material (PSM), polylactic acid (PLA), poly(butylene succinate) (PBS) have realized mass industrial production. In 2013, PSM, PLA and PBS accounted for 87% of the world’s total capacity.

In 2013, demand from Europe and North America, the two main biodegradable plastic markets around the world, for biodegradable plastics accounted for 54% and 28%, respectively. Germany-based BASF, U.S.-based NatureWorks (Thailand’s PTT Chemical paid US$150 million for a 50% stake in NatureWorks in December 2011), Italy’s Novamont as well as the Netherlands-based Purac are the world’s major suppliers of biodegradable plastics, with capacity of 140 kt/a, 140 kt/a, 80 kt/a, 80 kt/a, respectively.

2014032602.png

China as one of the world’s important suppliers of biodegradable plastics accounts for about 20% of global production capacity. In 2009-2013, its biodegradable plastic capacity grew at a compound annual growth rate of over 21%. And, under the stimulus of favorable national policies as well as expanding range of applications, many domestic enterprises have embarked on new construction or expansion of biodegradable plastics.

As a leader in domestic plastics industry, Kingfa Sci & Tech Co., Ltd. mainly produces modified plastics, specialty engineering plastics, completely biodegradable plastics, carbon fiber and composite materials, of which, the 30 kt/a PBS and polybutylene succinate adipate (PBSA) has been put into operation in Zhuhai in 2011, the Phase II 90 kt/a PBSA expansion project will be launched. Meanwhile, Kingfa is also increasing intensity of downstream demand expansion. The company has signed biodegradable plastic mulch demonstrative application agreements with Xinjiang Production and Construction Corps, Guizhou, Shandong and other provinces and cities in early 2014.

Wuhan Huali Environment Technology Co., Ltd is a national biodegradable material industrial demonstration base, mainly engaged in PSM, ranking first in China’s biodegradable plastics industry with 40 kt/a PSM in 2013. Besides, the company’s 60 kt/a PSM are under construction, expected to be put into operation by mid-2014.

Global and China Biodegradable Plastics Industry Report, 2013-2016 mainly covers the followings:
20120114.gifSupply and demand, product mix, regional structure, competition pattern, development trends of global biodegradable plastics market;
20120114.gifSupply and demand, competition pattern, policies, development trends of Chinese biodegradable plastics market;
20120114.gifDevelopment status, competition pattern of biodegradable plastic product segments such as PSM, PLA, PHA, PBS;
20120114.gifOperation, biodegradable plastics business analysis and development of more than 20 domestic and foreign biodegradable plastics manufacturers.

1. Overview of Biodegradable Plastics Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain 

2. Global Biodegradable Plastics Market
2.1 Market Supply
2.2 Global Demand
2.3 Product Mix
2.4 Regional Structure
2.4.1 USA
2.4.2 Europe
2.4.3 Japan
2.4.4 Brazil
2.4.5 Thailand
2.5 Technology Trends
2.6 Competition Pattern
2.7 Development Trends

3. China Biodegradable Plastics Market
3.1 Market Supply
3.2 Market Demand
3.3 Competition Pattern
3.4 Policy Trends
3.5 Development Trends

4. Biodegradable Plastics Market Segments
4.1 Plastarch Material (PSM)
4.1.1 Development Status
4.1.2 Competition Pattern
4.2 Polylactic Acid (PLA)
4.2.1 Introduction
4.2.2 Development Status
4.2.3 Competition Pattern
4.3 Polyhydroxyalkanoates (PHA)
4.3.1 Development Status
4.3.2 Competition Pattern
4.4 Poly(Butylene Succinate) (PBS)
4.4.1 Introduction
4.4.2 Competition Pattern
4.5 Others
4.5.1 Polycaprolactone (PCL)
4.5.2 Polypropylene Carbonate (PPC)
4.5.3 Aliphatic-Aromatic Copolyester
4.5.4 Polyvinyl Alcohol (PVA)

5. Main Companies in the World
5.1 BASF
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Biodegradable Plastics Business
5.1.7 Business in China
5.1.8 Development Prospect
5.2 NatureWorks LLC
5.2.1 Profile
5.2.2 Business in China 
5.3 Novamont
5.4 Dupont
5.5 Mitsubishi Chemical
5.6 Showa Denko
5.7 PURAC
5.7.1 Profile
5.7.2 Production
5.7.3 Operation

6. Main Companies in China
6.1 Kingfa Sci & Tech Co., Ltd. (600143)
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Clients and Suppliers
6.1.6 PBS Biodegradable Plastics Business
6.1.7 R&D
6.1.8 Development Prospect
6.2 Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd. (002019)
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Clients and Suppliers
6.2.6 PBS Biodegradable Plastics Business
6.2.7 R&D
6.2.8 Development Prospect
6.3 Wuhan Huali Environment Technology Co., Ltd.
6.3.1 Profile
6.3.2 Operation
6.3.3 Development Prospect
6.4 Anqing Hexing Chemical Co., Ltd
6.4.1 Profile
6.4.2 Operation
6.4.3 Development Prospect
6.5 Others
6.5.1 Zhejiang Hisun Biomaterials Co., Ltd.
6.5.2 Ningbo Tianan Biologic Material Co., Ltd.
6.5.3 Zhejiang Tianhe Environmental Technology Co., Ltd.
6.5.4 Henan Yongle Biological Engineering Co., Ltd.
6.5.5 Maanshan Tong-Jie-Liang Biomaterials Co., Ltd.
6.5.6 Zhejiang Wafa Ecosystem Science & Technology Co., Ltd.  
6.5.7 Fujian Beststarch Biodegradable Material Co., Ltd.
6.5.8 Guangdong Shangjiu Biodegradable Plastics Co., Ltd.
6.5.9 Shandong Fuwin New Material Co., Ltd.
6.5.10 Tianjin Danhai Co., Ltd.
6.5.11 Zibo Qixiang Tengda Chemical Co., Ltd (002408)
6.5.12 Tianjin GreenBio Materials Co., Ltd.
6.5.13 Shenzhen BrightChina Industrial Co., Ltd.

7. Summary and Forecast
7.1 Summary
7.2 Supply and Demand Forecast
7.3 Plastic Film Forecast
Classification and Usage of Biodegradable Plastics (by Raw Materials)
Biodegradable Plastics Industry Chain
Capacity of Global Biodegradable Plastics and Non-biodegradable Plastics, 2010-2013
Global Bioplastic Capacity Structure by Variety, 2012
Global Biodegradable Plastic Demand and Growth Rate, 2005-2013
Global Biodegradable Plastic Demand Structure by Usage, 2013
Global Biodegradable Plastic Capacity Structure by Variety, 2013
Global Biodegradable Plastic Demand Structure by Region, 2013
Global Biodegradable Plastic Capacity Structure by Region, 2013
Major Events of Japanese Enterprises Engaged in Biodegradable Plastic Application Development, 2008-2013
Biodegradable Plastic Technology Development, 2008-2014
Capacity of Main Biodegradable Plastic Enterprises in the World, 2013
China’s Biodegradable Plastic Capacity and Growth Rate, 2009-2014
China’s Plastic Film Production and YoY Growth, 2005-2013
China’s Agricultural Film Production and YoY Growth, 2005-2013
Biodegradable Plastics Substitution for Plastic Film and Agricultural Film in China, 2012
Capacity of Main Biodegradable Plastics Enterprises in China, 2013 
Policies of China’s Bioplastics Industry, 2006-2013
Main Constituents and Source of PSM
Capacity Distribution of PSM Companies in the World, 2010-2020
Properties and Applications of PLA 
Capacity of Main PLA Companies in the World, 2010-2020
Main Application of PHA in Medicine
Evolution of PHA
Capacity of Main PHA Companies in the World, 2010-2020
Capacity of Main PBS Companies in the World, 2010-2020
Main PPC Companies in China, 2013
BASF’s Structure by Business, 2013
Sales and YoY Growth of BASF, 2002-2013
Net Income and YoY Growth of BASF, 2002-2013
Sales Breakdown of BASF by Business, 2012-2013
Sales Breakdown of BASF by Region, 2012-2013
Sales Structure of BASF by Region, 2013
Gross Margin and YoY Growth of BASF, 2006-2013
R&D Expenditures of BASF, 2009-2013
Number of New Patents
R&D Cost Structure of BASF by Department, 2013
BASF’s Key Projects under Construction
Constituents and Applications of Ecoflex and Ecovio
Product Categories and Applications of BASF’s Performance Polymers
Production and R&D Bases of BASF in China, 2013
Regional Distribution of BASF Companies in China, 2013
Sales and Growth Rate of BASF in China, 2007-2013
Sales and Net Income of BASF, 2011-2016
Main Products and Business Areas of PURAC, 2013
PURAC Production Plants, 2013
Distribution of PURAC Plants and Sales Offices, 2013
Sales and EBIT of PURAC, 2008-2015E
Sales Structure of PURAC by Sector, 2013
Capital Expenditure and Return on Investment of PURAC, 2009-2012
R&D Costs and % of Total Revenue of Kingfa, 2011-2013
Total Assets and Net Income of Xinfu Pharmaceutical-controlled Subsidiaries by Jun. 2013
Revenue and YoY Growth of Xinfu Pharmaceutical, 2006-2013
Net Income and YoY Growth of Xinfu Pharmaceutical, 2006-2013
Revenue Breakdown of Xinfu Pharmaceutical by Product, 2006-2013
Gross Margin of Xinfu Pharmaceutical by Product, 2006-2013
Xinfu Pharmaceutical’s Procurement from Top 5 Suppliers and % of Total Procurement, 2006-2012
Xinfu Pharmaceutical’s Revenue from Top 5 Clients and % of Total Revenue, 2006-2013
Revenue and Net Income of PBS Products of Xinfu Pharmaceutical, 2011-2013
R&D Costs and % of Total Revenue of Xinfu Pharmaceutical, 2008-2013
Revenue, Net Income and Growth Rate of Xinfu Pharmaceutical, 2011-2016E
Revenue and Total Profit of Wuhan Huali Environment Technology, 2007-2011
Revenue and Total Profit of Anqing Hexing Chemical, 2007-2008
Global Biodegradable Plastic Demand and Production Structure by Region, 2013
Biodegradable Plastic Capacity Comparison between Domestic and Foreign Enterprises, 2010-2020
China’s Production of Plastic Film and Agricultural Film, 2010-2016E

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

China Lactic Acid and Derivative Industry Report, 2013

China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their design...

China Human Vaccine Industry Report, 2012-2015

In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the...

China Blood Product Industry Report, 2012-2015

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due...

China Animal Vaccine Industry Report, 2012-2015

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Be...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统